These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 8759640
1. Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationships. Glase SA, Akunne HC, Heffner TG, Jaen JC, MacKenzie RG, Meltzer LT, Pugsley TA, Smith SJ, Wise LD. J Med Chem; 1996 Aug 02; 39(16):3179-87. PubMed ID: 8759640 [Abstract] [Full Text] [Related]
6. Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors. Reitz AB, Baxter EW, Codd EE, Davis CB, Jordan AD, Maryanoff BE, Maryanoff CA, McDonnell ME, Powell ET, Renzi MJ, Schott MR, Scott MK, Shank RP, Vaught JL. J Med Chem; 1998 Jun 04; 41(12):1997-2009. PubMed ID: 9622541 [Abstract] [Full Text] [Related]
9. New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure. Campiani G, Nacci V, Bechelli S, Ciani SM, Garofalo A, Fiorini I, Wikström H, de Boer P, Liao Y, Tepper PG, Cagnotto A, Mennini T. J Med Chem; 1998 Sep 24; 41(20):3763-72. PubMed ID: 9748351 [Abstract] [Full Text] [Related]
13. Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents. Norman MH, Rigdon GC, Hall WR, Navas F. J Med Chem; 1996 Mar 01; 39(5):1172-88. PubMed ID: 8676355 [Abstract] [Full Text] [Related]
15. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride. Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL. J Pharmacol Exp Ther; 1998 Oct 01; 287(1):167-86. PubMed ID: 9765336 [Abstract] [Full Text] [Related]
18. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ. J Pharmacol Exp Ther; 1997 Jul 01; 282(1):181-91. PubMed ID: 9223553 [Abstract] [Full Text] [Related]
19. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity. Hirokawa Y, Fujiwara I, Suzuki K, Harada H, Yoshikawa T, Yoshida N, Kato S. J Med Chem; 2003 Feb 27; 46(5):702-15. PubMed ID: 12593651 [Abstract] [Full Text] [Related]
20. Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones. Jaen JC, Wise LD, Heffner TG, Pugsley TA, Meltzer LT. J Med Chem; 1991 Jan 27; 34(1):248-56. PubMed ID: 1671416 [Abstract] [Full Text] [Related] Page: [Next] [New Search]